Target intelligence / Profile preview

Peripheral nerve myelin sheath

Molecular classification
Other (multilamellar membrane structure), Myelin basic protein (MBP), Myelin protein zero (P0), Peripheral myelin protein 22 (PMP22)
01

Overview

The peripheral nerve myelin sheath is a specialized, lipid-rich membrane produced by Schwann cells that spirally wraps around axons in the peripheral nervous system[2][7][9][5]. This sheath consists of up to hundreds of concentric layers, with each segment termed an internode and separated by nodes of Ranvier, where rapid signal “jumping” (saltatory conduction) takes place[7]. The membrane is composed mostly of lipids (70–80%) and proteins (20–30%), most notably myelin protein zero (P0), peripheral myelin protein 22 (PMP22), and myelin basic protein (MBP)[1][6][8]. The sheath insulates axons, enables rapid signal transmission, and helps maintain axon health and regeneration after injury[7][9]. Damage or genetic abnormalities in sheath components cause various peripheral neuropathies and inherited myelin disorders[3][6]. While the sheath itself is not a primary drug target, its failure is a crucial element in several neurological diseases.

Other names
Myelin sheath (in PNS context)Peripheral myelinSchwann cell myelin
02

Mechanism of action

Not applicable

03

Biological functions

Insulation of axonsAcceleration of nerve impulse conduction (saltatory conduction)Maintenance of axonal integrity and functionFacilitation of nerve regeneration after injurySegregation and clustering of ion channels at nodes of Ranvier
04

Disease associations

Neurodegenerative diseases (e.g., Charcot-Marie-Tooth disease, peripheral neuropathies)Demyelinating diseases (e.g., Guillain-Barré syndrome)Inherited myelin disorders
05

Safety considerations

Peripheral neuropathy risk with therapies affecting myelin-forming cellsLimited regenerative capacity after injuryPossible mis-targeting when aiming at constituent proteins (risk of off-target effects on other tissues)
06

Biomarkers

Biomarkers exist for constituent proteins such as PMP22 gene dosageAutoantibodies in inflammatory demyelination

Beyond the preview

Go deeper on Peripheral nerve myelin sheath.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peripheral nerve myelin sheath.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call